MedTrace Logo

Bread Structure and Postprandial Metabolic Responses

NCT05691686 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-03-05

No results posted yet for this study

Summary

The structural properties of bread are considered one of the most important factors that can affect its digestibility, glucose homeostasis and postprandial metabolic responses. The purpose of this study is to examine the effects of consumption of less processed whole grain bread products (wheat and fortified with legumes) in comparison with finely milled whole grain bread products on postprandial glycaemic response and appetite regulation.

Conditions

  • Postprandial Hyperglycemia

Interventions

OTHER

Finely milled whole wheat-legume bread

The intervention examines the effect of finely milled wheat-legume bread in subjects with normal body weight.

OTHER

Less processed whole wheat-legume bread

The intervention examines the effect of less processed whole wheat-legume bread in subjects with normal body weight.

OTHER

Less processed whole wheat bread

The intervention examines the effect of less processed whole wheat bread in subjects with normal body weight.

OTHER

White wheat bread

The intervention examines the reference food product in subjects with normal body weight.

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    collaborator OTHER

  • Harokopio University

    lead OTHER

Principal Investigators

  • Nikolaos Tentolouris, Professor · National and Kapodistrian University of Athens

  • Vaios Karathanos, Professor · Harokopio University of Athens

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-16
Primary Completion
2023-05-15
Completion
2023-10-31

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05691686 on ClinicalTrials.gov